You are here:HomeCorporates

Pfizer mulls buying Strides Arcolab's Agila Specialties - report

Pfizer mulls buying Strides Arcolab's Agila Specialties - report

close

New York:

Pfizer is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab, for a possible price of $2 billion (Rs 10,886.31 crore), Bloomberg reported on Monday.

Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.

A Pfizer spokeswoman said the company does not comment on market rumours or speculation.

Agila makes cancer treatments and antibiotics, Bloomberg said.

Copyright @ Thomson Reuters 2013

Story first published on: January 15, 2013 10:13 (IST)

Tags: Pfizer, Agila Specialties, Strides Arcolab, India, Cancer, antibiotics

MORE FROM NDTV

FROM THE WEB

MORE FROM THE WEB
MORE FROM NDTV

For Profit Update,
Follow NDTV on Pinterest

Social Sharing

Advertisement

Advertisement

Portfolio
 

More From NDTV

More From the WEB

Don't Miss

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2014. All rights reserved.